Bufuralol
Overview of the beta-blocker Bufuralol
| Bufuralol | |
|---|---|
|
|
Bufuralol is a beta-adrenergic receptor antagonist used primarily in the treatment of hypertension and certain types of cardiac arrhythmias. It is a non-selective beta-blocker, meaning it affects both beta-1 and beta-2 receptors.
Pharmacology[edit]
Bufuralol works by blocking the action of epinephrine and norepinephrine on beta-adrenergic receptors, which are part of the sympathetic nervous system. This action results in a decrease in heart rate, cardiac output, and blood pressure, making it effective in managing hypertension and arrhythmias.
Mechanism of Action[edit]
Bufuralol binds to beta-adrenergic receptors, preventing the usual binding of catecholamines. This inhibition reduces the effects of sympathetic nervous system stimulation, leading to decreased heart rate and myocardial contractility. The drug's non-selective nature means it can also affect beta-2 receptors, which are found in the bronchi and vascular smooth muscle.
Clinical Use[edit]
Bufuralol is used in the management of:
- Hypertension
- Angina pectoris
- Certain types of arrhythmias
Side Effects[edit]
Common side effects of bufuralol include:
Less common but more serious side effects can include:
Metabolism[edit]
Bufuralol is metabolized primarily in the liver by the cytochrome P450 enzyme system, particularly by CYP2D6. This enzyme is known for its genetic polymorphism, which can lead to variability in drug metabolism among different individuals.
Chemical Structure[edit]

Bufuralol is a racemic mixture, meaning it contains two enantiomers. The chemical structure includes a phenyl group and a butyl side chain, which are characteristic of many beta-blockers.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian